Gupta Deepashree, Kirn Meredith, Jamkhana Zafar A, Lee Richard, Albert Stewart G, Rollins Kimberly M
Department of Internal Medicine, Division of Endocrinology, Saint Louis University School of Medicine, United States.
Department of Pharmacy, St. Luke's Hospital, St. Louis, MO, United States.
Diabetes Metab Syndr. 2017 Oct-Dec;11(4):265-271. doi: 10.1016/j.dsx.2016.09.008. Epub 2016 Sep 15.
To assess the efficacy of a unified hyperglycemia and diabetic ketoacidosis (DKA) insulin infusion protocol (IIP), based on an Excel algorithm and implemented as an electronic order set, in achieving glycemic targets and minimizing hypoglycemia.
An IIP was instituted in medical and surgical intensive care units for post-cardiac surgery (PCS) and other stress hyperglycemia (SH), diabetes hyperglycemia (DH), and DKA. The IIP initiated therapeutic insulin rates at elevated blood glucose (BG), and decreased insulin when target range was achieved. A convenience sample (n=62) was studied; 20 PCS, 15 with DH, 9 with SH, 8 with diabetes on vasopressors, 7 with diabetes on glucocorticoids and 3 with DKA were assessed.
The protocol maintained BG at 144±24.7mg/dL for PCS and 167±36mg/dL for patients with diabetes mellitus. It maintained acceptable target range (ATR) (100mg/dL-180mg/dL) 89% of the time for PCS and 67% of the time for patients with diabetes mellitus. There were no measurements of BG<70mg/dL. The protocol lowered the BG at a similar rate and time period in those with diabetes, DKA and those with or without vasopressors or glucocorticoids. To determine long-term efficacy, a retrospective review of Point of Care (POC) RALS (Remote Automated Data System) BG data 2 years post implementation demonstrated fewer episodes of hypoglycemia<70mg/dL and hyperglycemia>240mg/dL and more BG values within ATR.
This IIP maintained ATR without hypoglycemia for patients in the ICU setting without requiring complex nursing calculations.
评估基于Excel算法并作为电子医嘱集实施的统一高血糖和糖尿病酮症酸中毒(DKA)胰岛素输注方案(IIP)在实现血糖目标和减少低血糖方面的疗效。
在心胸外科术后(PCS)以及其他应激性高血糖(SH)、糖尿病性高血糖(DH)和DKA的内科及外科重症监护病房实施IIP。IIP在血糖(BG)升高时启动治疗性胰岛素输注速率,并在达到目标范围时减少胰岛素用量。研究了一个便利样本(n = 62);评估了20例PCS患者、15例DH患者、9例SH患者、8例使用血管加压药的糖尿病患者、7例使用糖皮质激素的糖尿病患者和3例DKA患者。
该方案使PCS患者的BG维持在144±24.7mg/dL,糖尿病患者的BG维持在167±36mg/dL。它使PCS患者89%的时间以及糖尿病患者67%的时间维持在可接受目标范围(ATR)(100mg/dL - 180mg/dL)内。未出现BG<70mg/dL的测量值。该方案在糖尿病患者、DKA患者以及使用或未使用血管加压药或糖皮质激素的患者中,以相似的速率和时间段降低BG。为确定长期疗效,对实施后2年的即时护理(POC)RALS(远程自动数据系统)BG数据进行回顾性分析,结果显示<70mg/dL的低血糖发作和>240mg/dL的高血糖发作减少,且更多BG值处于ATR范围内。
该IIP在重症监护病房环境中为患者维持了ATR且无低血糖发生,无需复杂的护理计算。